A recent study of more than a million children shows that Pfizer's mRNA COVID-19 vaccine has negative efficacy for the youngest children it’s recommended for.
Madam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Court. My fellow Americans.
A family whose 21-year-old son developed a life-threatening reaction to Pfizer’s COVID vaccine has been waiting six months to learn if the U.S. government’s Countermeasures Injury Compensation Program will help cover their son’s medical bills, but there’s been no response from the program.
A German health insurer BKK ProVita said an analysis of data collected from more than 10 million people suggests COVID vaccine side effects are “significantly” underreported. The company said its analysis revealed a “significant alarm signal” and said "a risk to human life cannot be ruled out.”
The Joint Committee on Vaccination and Immunization (JCVI), an independent group of experts who advise the UK’s government health departments on immunizations published a report on 16 February stating, ‘JCVI advises a non-urgent offer at two 10mcg doses of the Pfizer-BioNTech Covid-19 vaccine to children aged 5 to 11 years of age who are not in a clinical risk group.’
